Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Impact of Treatment Delays on Patient Outcomes
Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.
EP: 1.Emerging Agents in IPF Treatment
EP: 2.IPF and PDE4B Inhibitors
EP: 3.Importance of Patient-Reported Outcomes
EP: 4.Future Possibilities in IPF Treatment
EP: 5.Advice for Clinicians Treating IPF
EP: 6.Current Standard of Care in IPF
EP: 7.Therapeutic Response and Disease Progression
EP: 8.Key Considerations for Selecting IPF Treatment
EP: 9.Economic Impact of IPF
EP: 10.Unmet Needs in IPF Landscape
EP: 11.Overview of Idiopathic Pulmonary Fibrosis (IPF)
EP: 12.Impact of IPF on Quality of Life and Financial Considerations
EP: 13.Diagnosing IPF: Key Tests, Time to Diagnosis, and Importance of Early Detection
EP: 14.Clinical Presentation and Risk Factors
EP: 15.Impact of Comorbidities on IPF Management
EP: 16.Overcoming Treatment Barriers: Strategies for Success
Now Viewing
EP: 17.Impact of Treatment Delays on Patient Outcomes
Video content above is prompted by the following:
How does a delay in treatment affect patient outcomes and disease progression?
Related Videos
Related Content
